• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number T505C223
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Aortic Valve Stenosis (1717); Dizziness (2194)
Event Date 12/06/2013
Event Type  Injury  
Manufacturer Narrative
Upon receipt at medtronic¿s quality laboratory, the valve appeared slightly distorted with the stent posts deflected.All leaflets were slightly stiff but flexible, except where host tissue extended on the inflow and outflow.A small abrasion through the free margin and lunula of the left cusp adjacent to the non-coronary left commissure appeared to be due to contact with the bias cloth along the stent post.The free margin of the non-coronary cusps appeared to fold back and adhere to the host tissue on the outflow.A small fenestration measuring 1.5 millimeters was observed in the lunula of the left cusp.Small tears through the free margins of the right and non-coronary cusps on the top of the right non-coronary commissure appeared to be damage associated with explant.The non-coronary left and left right commissures were intact.Small tears on the top of the right non-coronary commissure appeared to have occurred during explant.Glistening off-white pannus partially covered the sewing ring on the inflow, to the tissue and base stitching, into all inferior coaptive areas, along the inflow margin of attachment and one to five millimeters onto all cusps, reducing the i nflow orifice area.Pannus remained attached to the sewing ring on the outflow adjacent to the left cusp with remnants on the outflow rail adjacent to the right and non-coronary cusps.Brown thrombotic-appearing host tissue filled and stiffened the non-coronary cusp on the outflow.Radiography showed trace mineralization in the host tissue along the sewing ring.The device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Based on the returned product analysis, the reported stenosis and high gradient could have led to thrombus filling the cusp outflow, resulting in an immobile leaflet.Also, the pannus noted on the inflow tissue area could have led to an insufficient effective orifice area and immobile leaflet and compromised forward blood flow.Pannus overgrowth and thrombus are an inherent risk of surgical valve replacement and are addressed in the device risk management files.Pannus (host tissue overgrowth) and thrombus are generally considered patient-related conditions.High gradients- and stenosis-related failure modes are addressed in the device risk management files.
 
Event Description
Medtronic received information that 11 months post implant of this bioprosthetic valve, the patient was noted to have high gradients (approximately 70mmhg) and stenosis.The patient was asymptomatic and was discharged.At 34 months post-implant, the patient's gradient was 120mmhg; the patient was still asymptomatic except for a report of lightheadedness.Subsequently the valve was explanted and replaced.No further adverse patient effects were reported.
 
Manufacturer Narrative
The device has been returned for analysis, the analysis is in progress.Once the analysis is complete, a supplemental report will be submitted.(b)(4).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key4357336
MDR Text Key12753592
Report Number2025587-2014-01025
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P980043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,company representati
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/08/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/23/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/21/2016
Device Model NumberT505C223
Device Catalogue NumberT505C223
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/04/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/08/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/13/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00063 YR
Patient Weight78
-
-